TLDR yields 0.54% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, TLDR + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TLDR + PFE for your $10,000?
TLDR uses a laddered maturity approach to a portfolio of US T-Bills, targeting a dollar-weighted average maturity of approximately 60 days. Investments primarily consist of T-Bills with remaining maturities of six months or less, and may also hold cash, cash equivalents, or treasury-backed money market instruments. The sub-adviser manages the ladder and reinvestment timing to optimize yield along the front end of the US Treasury curve, and may tactically adjust the portfolios average maturity. It may be extended when market conditions favor slightly longer-dates bills, or reduced to 30 days or less to preserve liquidity or limit interest-rate risk. The strategy spreads investments across multiple near-term maturities to help manage interest-rate exposure and generate regular cash flows. As positions mature, the fund continuously rolls the portfolio into newly issued T-Bills at market rates, which may result in high portfolio turnover.
Full TLDR Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.